Jazz Pharmaceuticals plc and ImmunoGen, Inc. announced that the companies have entered into a collaboration and option agreement granting Jazz...
Read more
Antibe Therapeutics has announced that it has received approval from Health Canada to initiate a Phase 2, double-blind, gastrointestinal endoscopy...
Read more
The Phase 3 GENESIS trial is aimed at evaluating the safety, tolerability and efficacy of the combination treatment of BL-8040...
Read more
Boehringer Ingelheim and pharmaceutical company Pharmaxis announce that Boehringer Ingelheim has initiated a European and North American Phase IIa trial...
Read more
Genentech, a member of the Roche Group , announced that the U.S. FDA has accepted the company’s supplemental Biologics License...
Read more
Aurobindo Pharma Limited is pleased to announce that the company has received tentative approval from the U.S. FDA under the...
Read more
Samsung Bioepis Co., Ltd. announced that it has entered into a strategic collaboration agreement with Takeda Pharmaceutical Company Limited to...
Read more
Astellas Pharma Inc. announced that the first patient was dosed in the registrational Phase 3 MORPHO trial of gilteritinib, the...
Read more
Ritter Pharmaceuticals, a developer of novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases, today announced...
Read more
Aurobindo Pharma Limited is pleased to announce that the company has received final approval from the US Food & Drug...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
